ENDRA LIFE SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2811 USD | -10.88% |
|
-3.24% | -86.74% |
| 14/05 | Transcript : ENDRA Life Sciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 14/05 | Endra Life Sciences Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.48M | - | - | - | - | - | |
| 62.59B | - | |||||
| 41.18B | ||||||
| 40.29B | ||||||
| 27.9B | ||||||
| 26.21B |
